The PennZone

  • Home
  • Business
  • Health
  • Technology
  • Non-profit
  • Financial
  • Services
  • Entertainment
  • Construction

New Study Reveals Alarming Cardiac Risks Associated with Electroshock Treatment
The PennZone/10283471

Trending...
  • Men's Health Network Highlights Major 2025 Achievements & Launches New Donation Platform For Greater Impact
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • Australian Aboriginal Cultural Immersions and First Nations Workshops
Study Reveals Cardiac Risks Associated with ECT
The mental health industry watchdog, CCHR, says informed consent is breached every time patients are not warned of the brain damage, long-term memory loss, and cardiac risks, including death, associated with electroshock, per the study.

LOS ANGELES - PennZone -- A new study has determined that as many as 1 in 15 people who receive electroshock treatment face life-threatening heart problems, which can lead to death. John Read, Ph.D., a Professor of Psychology at the University College of London critiqued studies of electroconvulsive therapy (ECT) and cited a 2019 review that he says misrepresented data and falsely asserted that ECT is safe. In reality, cardiac events are the leading cause of death for those subjected to shock treatment.[1] The Citizens Commission on Human Rights International, a mental health industry watchdog, says this critical information must be transparently communicated to patients recommended for ECT, including the risks of permanent brain damage and memory loss. According to Dr. Read's study, "the ethical principle of informed consent is being routinely breached by ECT psychiatrists."

Jan Eastgate, President of CCHR International, says that for decades there has been a cover-up of the seriousness of the effects of ECT, which sends up to 460 volts of electricity through the brain, causing a grand mal seizure. "Electroshock has no place in mental health treatment and should be banned," she said, adding, "Given without a patient's consent is internationally recognized as constituting torture."

According to U.S. expert, Ken Castleman, a biomedical engineer, "ECT stimulates the sympathetic nervous system, which controls many aspects of cardiovascular function. The powerful electrical discharge causes a spike in blood pressure. The intense stress that the ECT-induced seizure places on the heart increases the risk of adverse cardiovascular events, especially in patients who have pre-existing cardiac conditions."

More on The PennZone
  • 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
  • Tickeron Launches Next-Gen AI Corridor Bots: Consistent Exits for Stocks and ETFs
  • From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
  • Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."
  • Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation

Dr. Read reports, "The obligation to ensure informed consent is a core ethical principle of all health and mental health professionals." Yet, "Various official reports, most psychiatric textbooks, and many patient information leaflets have claimed, for decades, that the risk of death from ECT is so rare as to be inconsequential," including an American Psychiatric Association (APA) ECT Task Force Report on ECT. "It should be noted that six of the eight task force members were directors of ECT services." The group included three members who were financially involved with companies manufacturing ECT machines, Dr. Read wrote.

Citing the 2023 joint guidance by the World Health Organization/United Nations, Dr. Read continued: "People being offered ECT should be made aware of all its risks and potential short- and long-term harmful effects, such as memory loss and brain damage. ECT is not recommended for children, and this should be prohibited through legislation."

The study further discusses the death rate:
  • Of 8,148 ECT recipients in Texas, seven died within 2 days of their last ECT. Even excluding the two that the researchers believed were "unlikely to have been related to ECT," this is a "rate of 1 per 1,630 people. If one includes the additional eight that died, from 'cardiac events' in the following 12 days, the rate is 1 per 627."
  • A 2019 review of 43 ECT studies with mortality data, including more than 75,000 patients, calculated, "All-cause mortality was 0.42 deaths per 1,000 patients." This is 1 per 2,380 people, more than four times greater than the official position of the APA of 1 per 10,000.
  • A 2023 Swedish register-based study was comprehensive in finding that of 20,225 ECT patients, 123 (0.61%) died of "medical causes" within 30 days of their last ECT—one death per 164 people. At one per 413 patients, the 49 cardiac-related deaths represented the most common medical cause of post-ECT death (40%). This was surpassed only by the 93 suicides (1 per 217).  In total, 15 of the 23 patients who died within 24 hours of ECT were cardiovascular deaths.
As Dr. Read points out, in 2001, the APA acknowledged that "evidence has shown that ECT can result in persistent or permanent memory loss." In 2018, an ECT device manufacturer included "permanent brain damage" in its list of risks, yet this information was not being forwarded to patients.

More on The PennZone
  • Canterbury Hotel Group Announces the Opening of the TownePlace Suites by Marriott Portland Airport
  • Heritage at South Brunswick's Resort-Style Amenities for Any Age and Every Lifestyle
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • Hummell Brothers Celebrates 100 Years as Trusted Lighting Store in Jeannette
  • Record Revenues, Debt-Free Momentum & Shareholder Dividend Ignite Investor Attention Ahead of 2026–2027 Growth Targets: IQSTEL (N A S D A Q: IQST)

In the U.S., adolescents and even children five years old and younger have been electroshocked. Dr. Read found "rates of memory deficits in more than two-thirds of child and adolescent ECT patients" that were passed off as "acceptable" and misrepresented as a "high level of safety." Dr. Read wrote to the journal stating: "The use of sufficient electricity, once, on a developing brain, in order to cause a seizure in that young brain, is a very serious matter. To do so five or six times in a few weeks is almost bound to cause brain damage in a significant number of recipients. The average age of these youngsters was just 15.5 years. Most (62 %) were girls. When even the psychiatrists themselves acknowledge that 69 % have impaired memories as a result, this does not indicate a treatment with a 'high' degree of safety."

The main cardiac events Dr. Read found are myocardial infarction (heart attack), life-threatening arrhythmia (irregular heartbeat), acute pulmonary edema (fluid on the lungs), pulmonary embolism (blood clots), acute heart failure, and cardiac arrest.

In light of these grave risks, CCHR welcomes the recent news that electroshock is nearly on the brink of disappearing due to public awareness campaigns, including CCHR's documentary, Electroshock: Therapy or Torture. "It's an incredible story that goes back decades," says Harold Sackeim, a psychologist and major proponent of ECT, who is worried that exposure of ECT could be "successful at killing an industry."

Ms. Eastgate responds, "It is far better that the multi-billion-dollar electroshock industry be killed off rather than its patients. Their safety must be the priority. The current study and many others reflect the ongoing concerns that ECT should be banned."

About CCHR: Established in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz, CCHR has secured state bans of ECT use on minors. It also had Deep Sleep Treatment (DST), which includes ECT, banned in Australia, which last year the WHO said should be prohibited worldwide.

Source:

[1] Read, J. 2024. Major adverse cardiac events and mortality associated with electroconvulsive therapy: Correcting and updating a 2019 meta-analysis. Ethical Human Psychology and Psychiatry, repository.uel.ac.uk/item/8xyx0

Contact
Citizens Commission on Human Rights
***@cchr.org


Source: Citizens Commission on Human Rights
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
  • Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
  • Ring in the Season with Free Holiday Jazz from The Jazz Sanctuary
  • America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
  • BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity
  • "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
  • Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
  • Fenix Consulting Group Expands Orange County Office to Meet Growing Client Demand
  • Signature Smiles Dental Group Unveils New User-Friendly Website
  • CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
  • QwickContractReview.com Launches $19 Contract Review Service to Protect Consumers from Hidden Contract Risks
  • Local Holistic Consultant Pharmacist Featured on National Podcast as FDA Updates Hormone Therapy Safety
  • 100% Bonus Depreciation Places New Spotlight on Off The Hook Yacht Sales Inc. (N Y S E: OTH) as a Major Player in the $57 Billion U.S. Marine Market
  • CNCPW Benchmarks Global Industry Standards: Integrating SEC Compliance with 3 Million TPS Architecture for Institutional Infrastructure
  • The Patina Collective & Artist Jesse Draxler Debut "The Machine of Loving Grace"
  • Smile! Dental Center Named 2025 "Best Dentist" in North Pittsburgh, Celebrating High-Tech Care and Heartfelt Service
  • Dr. Johnny Shanks, As Seen on TV, Announces 20% Off Dental Implant Treatments | Tennessee's Leading All-on-X Provider
  • Star Sleep & Wellness Expands to Pearland, Texas — Bringing Life-Changing Sleep Care to More Communities
  • Fort Lauderdale Dentist Dr. Taskonak & IN A DAY SMILE Receive Emmy Nomination for Life-Changing Documentary "The Weight of a Smile"

Popular on PennZone

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 375
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers - 186
  • Light Her Way Launches New Cohort of Board of AdviseHERS to Prepare Women for Board-Ready Leadership
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Corcoran DeRonja Real Estate Welcomes Siobhán Simões to Its Growing Team
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
  • purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint

Similar on PennZone

  • From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
  • Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
  • "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
  • Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
  • Signature Smiles Dental Group Unveils New User-Friendly Website
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us